Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters

Tomomichi Iwaki1, Kaoru Ishizaki, Shuji Kinoshita

  • 1Research Laboratory III (Immunology), Pharmaceuticals Research Division, Mitsubishi Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. iwaki.tomomichi@mh.m-pharma.co.jp

Insights

Ursodeoxycholic acid (UDCA) protects hamsters from liver injury caused by chenodeoxycholic acid (CDCA). UDCA reduces toxic bile acid accumulation, improving liver health.

Area of Science:

  • Hepatology
  • Toxicology
  • Gastroenterology

Background:

  • Chenodeoxycholic acid (CDCA) is a hydrophobic bile acid that can induce liver injury.
  • Elevated levels of hydrophobic bile acids are associated with liver damage and cytotoxicity.
  • Understanding the protective mechanisms of bile acids is crucial for managing liver diseases.

Purpose of the Study:

  • To evaluate the protective effects of ursodeoxycholic acid (UDCA) against CDCA-induced liver injury in a hamster model.
  • To investigate the correlation between liver injury markers and bile acid profiles in the liver.
  • To elucidate the mechanism by which UDCA mitigates CDCA-induced hepatotoxicity.

Main Methods:

  • Liver injury was induced in hamsters by oral administration of 0.5% CDCA in feed for 7 days.
  • Ursodeoxycholic acid (UDCA) was administered at doses of 50 mg/kg and 150 mg/kg for the final 3 days of the experiment.
  • Liver histology and serum alanine aminotransferase (ALT) levels were assessed to confirm and quantify liver injury. Bile acid profiles in the liver were analyzed.

Main Results:

  • CDCA administration significantly increased serum ALT levels (over 10-fold) and caused histological evidence of liver injury.
  • A marked increase in total and hydrophobic bile acids, including CDCA and lithocholic acid (LCA), was observed in the liver.
  • UDCA treatment dose-dependently reduced serum ALT levels and improved liver histology, with significant reductions observed at both 50 mg/kg and 150 mg/kg doses.
  • UDCA decreased the hepatic concentrations of hydrophobic bile acids, leading to a reduction in overall liver bile acid levels.

Conclusions:

  • Ursodeoxycholic acid (UDCA) demonstrates significant protective effects against oral CDCA-induced liver damage in hamsters.
  • The hepatoprotective mechanism of UDCA involves the reduction of cytotoxic hydrophobic bile acids, such as CDCA and LCA, in the liver.
  • These findings highlight UDCA's potential therapeutic role in managing liver conditions associated with bile acid dysregulation.
Abstract

Related Concept Videos